US Stock MarketDetailed Quotes

LCTX Lineage Cell Therapeutics

Watchlist
  • 0.504
  • -0.096-16.02%
Close Nov 22 16:00 ET
  • 0.520
  • +0.016+3.20%
Post 19:59 ET
115.05MMarket Cap-5039P/E (TTM)

Lineage Cell Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-14.89%-5.79M
17.42%-5.18M
48.56%-5.78M
-2,797.45%-28.57M
27.51%-6.02M
8.08%-5.04M
11.24%-6.27M
-151.32%-11.24M
104.49%1.06M
-41.38%-8.3M
Net income from continuing operations
58.07%-3M
-10.96%-5.77M
-48.91%-6.56M
18.50%-21.48M
25.90%-4.71M
-17.04%-7.16M
23.28%-5.2M
37.91%-4.4M
39.10%-26.35M
78.20%-6.36M
Operating gains losses
-148.03%-452K
-41.67%406K
-11.53%376K
-81.65%776K
-1,290.74%-1.29M
-53.28%941K
-69.12%696K
391.10%425K
151.00%4.23M
105.58%108K
Depreciation and amortization
-19.89%141K
-16.47%142K
2.34%175K
-4.81%692K
1.16%175K
-8.81%176K
-7.10%170K
-3.93%171K
-16.72%727K
-9.42%173K
Deferred tax
--0
--0
--0
---1.8M
--0
--0
--0
---1.8M
--0
--0
Other non cash items
37.40%-82K
51.58%-92K
96.93%-10K
-9.70%-588K
116.86%59K
---131K
---190K
---326K
-348.15%-536K
-2,600.00%-350K
Change In working capital
-2,678.36%-3.72M
62.66%-1.13M
85.34%-929K
-157.76%-10.8M
53.62%-1.31M
85.56%-134K
35.19%-3.02M
-123.36%-6.34M
-11.34%18.7M
-113.31%-2.83M
-Change in receivables
-2,916.67%-169K
33.88%-160K
603.16%668K
-100.89%-446K
-382.41%-305K
-93.68%6K
-15.24%-242K
-99.81%95K
5,970.95%50.31M
114.34%108K
-Change in prepaid assets
15.03%375K
-44.37%321K
123.02%195K
-193.72%-418K
-567.61%-474K
523.38%326K
2,647.62%577K
-247.82%-847K
719.44%446K
-106.14%-71K
-Change in payables and accrued expense
-209.90%-533K
-40.38%-671K
83.42%-574K
87.73%-2.3M
202.83%1.16M
-70.73%485K
-47.08%-478K
81.68%-3.46M
-186.40%-18.7M
-105.30%-1.13M
-Change in other working capital
-257.10%-3.4M
78.53%-618K
42.57%-1.22M
42.75%-7.65M
2.53%-1.7M
63.47%-951K
30.60%-2.88M
56.40%-2.12M
-3,614.21%-13.35M
-311.11%-1.74M
Cash from discontinued investing activities
Operating cash flow
-14.89%-5.79M
17.42%-5.18M
48.56%-5.78M
-2,797.45%-28.57M
27.51%-6.02M
8.08%-5.04M
11.24%-6.27M
-151.32%-11.24M
104.49%1.06M
-41.38%-8.3M
Investing cash flow
Cash flow from continuing investing activities
83.22%3.89M
-145.89%-8.79M
-100.25%-38K
200.63%46.45M
290.94%9.74M
105.19%2.12M
19,851.55%19.16M
33,634.78%15.43M
-573.67%-46.16M
-3,394.52%-5.1M
Net PPE purchase and sale
19.42%-112K
80.47%-50K
79.79%-38K
-63.20%-674K
-668.75%-91K
51.40%-139K
-163.92%-256K
-308.70%-188K
-21.47%-413K
110.96%16K
Net investment purchase and sale
76.91%4M
-145.03%-8.74M
--0
203.01%47.12M
292.13%9.83M
105.57%2.26M
--19.42M
--15.61M
---45.75M
---5.12M
Cash from discontinued investing activities
Investing cash flow
83.22%3.89M
-145.89%-8.79M
-100.25%-38K
200.63%46.45M
290.94%9.74M
105.19%2.12M
19,851.55%19.16M
33,634.78%15.43M
-573.67%-46.16M
-3,394.52%-5.1M
Financing cash flow
Cash flow from continuing financing activities
-100.37%-3K
-98.13%105K
1,402,000.00%14.02M
293.57%6.42M
-110.66%-13K
-16.29%807K
16,954.55%5.63M
-99.81%1K
-95.58%1.63M
-87.21%122K
Net issuance payments of debt
-8.33%-13K
12.50%-14K
0.00%-13K
-68.75%-54K
-44.44%-13K
-50.00%-12K
-128.57%-16K
-62.50%-13K
-60.00%-32K
-28.57%-9K
Net common stock issuance
--0
-99.43%33K
37,975.68%14.01M
4,929.01%6.59M
--0
--836K
64,422.22%5.79M
-126.43%-37K
-99.57%131K
--0
Proceeds from stock option exercised by employees
25.00%10K
200.00%87K
158.82%132K
-94.63%88K
--0
-99.21%8K
-72.64%29K
-86.61%51K
-77.36%1.64M
-85.38%142K
Net other financing activities
--0
---1K
---112K
-87.74%-199K
--0
34.21%-25K
----
----
90.37%-106K
90.91%-11K
Cash from discontinued financing activities
Financing cash flow
-100.37%-3K
-98.13%105K
1,402,000.00%14.02M
293.57%6.42M
-110.66%-13K
-16.29%807K
16,954.55%5.63M
-99.81%1K
-95.58%1.63M
-87.21%122K
Net cash flow
Beginning cash position
-12.42%30.17M
175.40%44.12M
201.54%35.99M
-78.79%11.94M
26.50%32M
-51.73%34.45M
-79.62%16.02M
-78.79%11.94M
69.60%56.28M
-58.75%25.3M
Current changes in cash
9.77%-1.9M
-174.86%-13.86M
95.94%8.2M
155.92%24.31M
127.93%3.71M
95.36%-2.11M
359.88%18.52M
-81.29%4.19M
-288.06%-43.47M
-162.25%-13.28M
Effect of exchange rate changes
111.18%38K
4.35%-88K
30.00%-70K
71.36%-250K
461.54%282K
46.37%-340K
22.69%-92K
-138.10%-100K
-4,265.00%-873K
-657.14%-78K
End cash Position
-11.54%28.31M
-12.42%30.17M
175.40%44.12M
201.54%35.99M
201.54%35.99M
26.50%32M
-51.73%34.45M
-79.62%16.02M
-78.79%11.94M
-78.79%11.94M
Free cash flow
-13.97%-5.9M
19.90%-5.23M
49.07%-5.82M
-4,626.32%-29.24M
26.27%-6.11M
10.23%-5.18M
8.87%-6.52M
-152.29%-11.43M
102.70%646K
-37.68%-8.29M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -14.89%-5.79M17.42%-5.18M48.56%-5.78M-2,797.45%-28.57M27.51%-6.02M8.08%-5.04M11.24%-6.27M-151.32%-11.24M104.49%1.06M-41.38%-8.3M
Net income from continuing operations 58.07%-3M-10.96%-5.77M-48.91%-6.56M18.50%-21.48M25.90%-4.71M-17.04%-7.16M23.28%-5.2M37.91%-4.4M39.10%-26.35M78.20%-6.36M
Operating gains losses -148.03%-452K-41.67%406K-11.53%376K-81.65%776K-1,290.74%-1.29M-53.28%941K-69.12%696K391.10%425K151.00%4.23M105.58%108K
Depreciation and amortization -19.89%141K-16.47%142K2.34%175K-4.81%692K1.16%175K-8.81%176K-7.10%170K-3.93%171K-16.72%727K-9.42%173K
Deferred tax --0--0--0---1.8M--0--0--0---1.8M--0--0
Other non cash items 37.40%-82K51.58%-92K96.93%-10K-9.70%-588K116.86%59K---131K---190K---326K-348.15%-536K-2,600.00%-350K
Change In working capital -2,678.36%-3.72M62.66%-1.13M85.34%-929K-157.76%-10.8M53.62%-1.31M85.56%-134K35.19%-3.02M-123.36%-6.34M-11.34%18.7M-113.31%-2.83M
-Change in receivables -2,916.67%-169K33.88%-160K603.16%668K-100.89%-446K-382.41%-305K-93.68%6K-15.24%-242K-99.81%95K5,970.95%50.31M114.34%108K
-Change in prepaid assets 15.03%375K-44.37%321K123.02%195K-193.72%-418K-567.61%-474K523.38%326K2,647.62%577K-247.82%-847K719.44%446K-106.14%-71K
-Change in payables and accrued expense -209.90%-533K-40.38%-671K83.42%-574K87.73%-2.3M202.83%1.16M-70.73%485K-47.08%-478K81.68%-3.46M-186.40%-18.7M-105.30%-1.13M
-Change in other working capital -257.10%-3.4M78.53%-618K42.57%-1.22M42.75%-7.65M2.53%-1.7M63.47%-951K30.60%-2.88M56.40%-2.12M-3,614.21%-13.35M-311.11%-1.74M
Cash from discontinued investing activities
Operating cash flow -14.89%-5.79M17.42%-5.18M48.56%-5.78M-2,797.45%-28.57M27.51%-6.02M8.08%-5.04M11.24%-6.27M-151.32%-11.24M104.49%1.06M-41.38%-8.3M
Investing cash flow
Cash flow from continuing investing activities 83.22%3.89M-145.89%-8.79M-100.25%-38K200.63%46.45M290.94%9.74M105.19%2.12M19,851.55%19.16M33,634.78%15.43M-573.67%-46.16M-3,394.52%-5.1M
Net PPE purchase and sale 19.42%-112K80.47%-50K79.79%-38K-63.20%-674K-668.75%-91K51.40%-139K-163.92%-256K-308.70%-188K-21.47%-413K110.96%16K
Net investment purchase and sale 76.91%4M-145.03%-8.74M--0203.01%47.12M292.13%9.83M105.57%2.26M--19.42M--15.61M---45.75M---5.12M
Cash from discontinued investing activities
Investing cash flow 83.22%3.89M-145.89%-8.79M-100.25%-38K200.63%46.45M290.94%9.74M105.19%2.12M19,851.55%19.16M33,634.78%15.43M-573.67%-46.16M-3,394.52%-5.1M
Financing cash flow
Cash flow from continuing financing activities -100.37%-3K-98.13%105K1,402,000.00%14.02M293.57%6.42M-110.66%-13K-16.29%807K16,954.55%5.63M-99.81%1K-95.58%1.63M-87.21%122K
Net issuance payments of debt -8.33%-13K12.50%-14K0.00%-13K-68.75%-54K-44.44%-13K-50.00%-12K-128.57%-16K-62.50%-13K-60.00%-32K-28.57%-9K
Net common stock issuance --0-99.43%33K37,975.68%14.01M4,929.01%6.59M--0--836K64,422.22%5.79M-126.43%-37K-99.57%131K--0
Proceeds from stock option exercised by employees 25.00%10K200.00%87K158.82%132K-94.63%88K--0-99.21%8K-72.64%29K-86.61%51K-77.36%1.64M-85.38%142K
Net other financing activities --0---1K---112K-87.74%-199K--034.21%-25K--------90.37%-106K90.91%-11K
Cash from discontinued financing activities
Financing cash flow -100.37%-3K-98.13%105K1,402,000.00%14.02M293.57%6.42M-110.66%-13K-16.29%807K16,954.55%5.63M-99.81%1K-95.58%1.63M-87.21%122K
Net cash flow
Beginning cash position -12.42%30.17M175.40%44.12M201.54%35.99M-78.79%11.94M26.50%32M-51.73%34.45M-79.62%16.02M-78.79%11.94M69.60%56.28M-58.75%25.3M
Current changes in cash 9.77%-1.9M-174.86%-13.86M95.94%8.2M155.92%24.31M127.93%3.71M95.36%-2.11M359.88%18.52M-81.29%4.19M-288.06%-43.47M-162.25%-13.28M
Effect of exchange rate changes 111.18%38K4.35%-88K30.00%-70K71.36%-250K461.54%282K46.37%-340K22.69%-92K-138.10%-100K-4,265.00%-873K-657.14%-78K
End cash Position -11.54%28.31M-12.42%30.17M175.40%44.12M201.54%35.99M201.54%35.99M26.50%32M-51.73%34.45M-79.62%16.02M-78.79%11.94M-78.79%11.94M
Free cash flow -13.97%-5.9M19.90%-5.23M49.07%-5.82M-4,626.32%-29.24M26.27%-6.11M10.23%-5.18M8.87%-6.52M-152.29%-11.43M102.70%646K-37.68%-8.29M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data